Upgrade to SI Premium - Free Trial

Amarin (AMRN), FDA Enter REDUCE-IT SPA; Second Efficacy Analysis Added

August 4, 2016 5:51 AM
Amarin Corporation plc (NASDAQ: AMRN) announced that the U.S. Food and Drug Administration (FDA) agreed to an amendment of the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News FDA Management Comments

Next Articles